TAUROLIDINE SUPPLY AGREEMENTSupply Agreement • December 31st, 2009 • CorMedix Inc. • Pharmaceutical preparations • New Jersey
THIS SUPPLY AGREEMENT is made and entered into as of December 7th, 2009 (the “Effective Date”) by and between CORMEDIX INC. 86 Summit Ave., Summit, NJ 07901, (together with its Affiliates, “Customer”) and NAVINTA, LLC, a corporation having an address at 1499 Lower Ferry Road, Ewing, NJ 08618 (“Manufacturer”).
MANUFACTURE DEVELOPMENT AGREEMENTManufacture Development Agreement • December 31st, 2009 • CorMedix Inc. • Pharmaceutical preparations • New Jersey
THIS MANUFACTURE AND DEVELOPMENT AGREEMENT (the “Agreement” or “Contract”) is entered into as of March 05, 2007 (the “Effective Date”), by and between CORMEDIX INC. (“CorMedix”), a limited liability company having an office and place of business at 787 Seventh Avenue, New York, New York 10019, U.S.A., and EMCURE PHARMACEUTICALS USA, INC. (“Emcure”) a New Jersey [corporation] with its principal place of business located at 21 B Cotters Lane, East Brunswick, New Jersey 08816.
AMENDMENT TO CONTRIBUTION AGREEMENTContribution Agreement • December 31st, 2009 • CorMedix Inc. • Pharmaceutical preparations
[*] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
CONTRIBUTION AGREEMENT BETWEEN SHIVA BIOMEDICAL, LLC, PICTON PHARMACEUTICALS, INC., PICTON HOLDING COMPANY, INC., AND THE STOCKHOLDERS OF PICTON PHARMACEUTICALS, INC.Contribution Agreement • December 31st, 2009 • CorMedix Inc. • Pharmaceutical preparations • New York
This Contribution Agreement (hereinafter referred to as this “Agreement”), executed as of July 28, 2006, is entered into by and between SHIVA BIOMEDICAL, LLC, a limited liability company duly organized under the laws of New Jersey having a place of business at 10810 Executive Center Drive, Danville Building, Suite 100, Little Rock, AR 22211 (“Shiva”), PICTON PHARMACEUTICALS, INC., a corporation duly organized and existing under the laws of the State of Delaware having a place of business at 787 Seventh Avenue, 48th Floor, New York, NY 10019 (“Picton”), PICTON HOLDING COMPANY, INC., a corporation duly organized and existing under the laws of the State of Delaware having a place of business at 787 Seventh Avenue, 48th Floor, New York, NY 10019 (the “Company”), and the stockholders of Picton executing a Joinder to this Contribution Agreement in the form attached hereto as Exhibit 16.1 (the “Stockholders”).
EXCLUSIVE LICENSE AND CONSULTING AGREEMENTExclusive License and Consulting Agreement • December 31st, 2009 • CorMedix Inc. • Pharmaceutical preparations
This Exclusive License and Consulting Agreement (the “Agreement”) is entered into by and between CorMedix, a Delaware limited liability company (the "Company"), and Hans-Dietrich Polaschegg (the “Consultant”) as of this 30 day of January, 2008 (the “Effective Date”). Exhibit A includes definitions of terms used but not otherwise defined within the body of this Agreement, and Exhibit A and such definitions shall be incorporated by reference to this Agreement.
LICENSE AND ASSIGNMENT AGREEMENT between ND PARTNERS LLC andLicense Agreement • December 31st, 2009 • CorMedix Inc. • Pharmaceutical preparations • New York
This License and Assignment Agreement (hereinafter referred to as this "Agreement"), effective this 30th day of January 2008 (the “Effective Date”), is entered into by and between ND Partners LLC, a Delaware limited liability company having a place of business at One Joy Street, Boston, MA 02108 (“Licensor”), and CorMedix, Inc., a Delaware corporation having a place of business at 86 Summit Avenue, Suite 301, Summit, NJ 07901 (the "Company").
STOCK PURCHASE AGREEMENTStock Purchase Agreement • December 31st, 2009 • CorMedix Inc. • Pharmaceutical preparations • New York
THIS STOCK PURCHASE AGREEMENT ("Agreement") is entered into as of April 18, 2006, by and between the undersigned (the "Purchaser") and PICTON PHARMACEUTICALS, INC., a Delaware corporation having a business address at 787 Seventh Avenue, 48th Floor, New York, New York 10019 (the “Company”).
